Marvel Gold Limited (MVL.AX)
AUD 0.01
(0.0%)
AUD 0.01
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -2.16 Million | -7.03 Million | -4.97 Million | -7.38 Million | -5.34 Million | -5.84 Million |
| Net Income | -7.08 Million | -8.2 Million | 20.52 Million | - | -7.48 Million | -8.04 Million |
| Depreciation & Amortization | 4304.00 | 177.52 Thousand | 111.44 Thousand | - | 55.21 Thousand | 49.91 Thousand |
| Deferred income taxes | -209.55 Thousand | -222.71 Thousand | 45.59 Thousand | - | 52.6 Thousand | -35.08 Thousand |
| Stock-based compensation | 202.32 Thousand | 505.44 Thousand | 1.2 Million | - | -149.58 Thousand | -138.65 Thousand |
| Change in working capital | -61.23 Thousand | -799.92 Thousand | -1.12 Million | - | 191.46 Thousand | 148.16 Thousand |
| Other non-cash items | 4.98 Million | 2.01 Million | -24.52 Million | - | 1.84 Million | 2.03 Million |
| Investing Cash Flow | 507.03 Thousand | 981 Thousand | 959.19 Thousand | -1.27 Million | -15.49 Thousand | -36.46 Thousand |
| Investments in PPE | - | -19 Thousand | -40.81 Thousand | -1.27 Million | -15.49 Thousand | -36.46 Thousand |
| Acquisitions | 130.04 Thousand | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | 376.99 Thousand | - | - | - | - | - |
| Other Investing Activities | 376.99 Thousand | 1 Million | 1 Million | - | - | - |
| Financing Cash Flow | 1.75 Million | 5.2 Million | 4.19 Million | 10.27 Million | 4.43 Million | 5.27 Million |
| Debt repayment | - | - | - | - | -1.35 Million | -5.19 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -142.56 Thousand | -73.84 Thousand | - | -795.09 Thousand | -407.07 Thousand | -21.99 Thousand |
| Common Stock Issuance | 1.75 Million | 5.28 Million | 4.19 Million | 11.06 Million | 3.45 Million | 104.56 Thousand |
| Other Financing Activities | 1.75 Million | 5208.55 | 8.39 Million | - | 4.11 Million | 15.57 Million |
| Accounts receivables | 97.48 Thousand | 219.58 Thousand | 290.37 Thousand | - | 175.56 Thousand | -154.12 Thousand |
| Accounts payables | -96.1 Thousand | -86.75 Thousand | -20.69 Thousand | - | -12.67 Thousand | 218.73 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -62.61 Thousand | -932.75 Thousand | -1.39 Million | - | 28.57 Thousand | 83.55 Thousand |
| Cash at beginning of period | 1.18 Million | 1.95 Million | 304.63 Thousand | 304.63 Thousand | 1.26 Million | 1.83 Million |
| Cash at end of period | 1.33 Million | 1.18 Million | 1.95 Million | 1.5 Million | 304.63 Thousand | 1.26 Million |
| Capital Expenditure | - | -19 Thousand | -40.81 Thousand | -1.27 Million | -15.49 Thousand | -36.46 Thousand |
| Effect of forex changes on cash | 54.52 Thousand | 75.84 Thousand | 528.19 Thousand | -414.01 Thousand | -36.86 Thousand | 35.97 Thousand |
| Net cash flow / Change in cash | 155.84 Thousand | -773.15 Thousand | 1.64 Million | 1.2 Million | -960.15 Thousand | -574.09 Thousand |
| Free Cash Flow | -2.16 Million | -7.05 Million | -5.01 Million | -8.65 Million | -5.36 Million | -5.88 Million |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -7.08 Million | -2.04 Million | -1.02 Million | -5.04 Million | -2.52 Million | -8.2 Million |
| Depreciation & Amortization | 4304.00 | 1789.00 | 1.17 Million | 2515.00 | 1258.00 | 177.52 Thousand |
| Deferred income taxes | -209.55 Thousand | -87.89 Thousand | - | - | - | -222.71 Thousand |
| Stock-based compensation | 202.32 Thousand | 66.88 Thousand | 66.88 Thousand | 34.27 Thousand | 34.27 Thousand | 505.44 Thousand |
| Change in working capital | -61.23 Thousand | 17.43 Thousand | 17.43 Thousand | - | - | -799.92 Thousand |
| Other non-cash items | 4.98 Million | 1.03 Million | -738.9 Thousand | 3.89 Million | 1.9 Million | 2.01 Million |
| Investing Cash Flow | 507.03 Thousand | 138.31 Thousand | 69.15 Thousand | 368.72 Thousand | 184.36 Thousand | 981 Thousand |
| Investments in PPE | - | - | - | - | - | -19 Thousand |
| Acquisitions | 130.04 Thousand | 130.04 Thousand | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | 376.99 Thousand | - | - | - | - | - |
| Other Investing Activities | 376.99 Thousand | 8273.00 | 69.15 Thousand | 368.72 Thousand | 184.36 Thousand | 1 Million |
| Financing Cash Flow | 1.75 Million | -28.56 Thousand | -14.28 Thousand | 1.78 Million | 893 Thousand | 5.2 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -142.56 Thousand | - | - | - | - | -73.84 Thousand |
| Common Stock Issuance | 1.75 Million | -28.56 Thousand | - | 1.78 Million | - | 5.28 Million |
| Other Financing Activities | 1.75 Million | -14.28 Thousand | -14.28 Thousand | 893 Thousand | 893 Thousand | 5208.55 |
| Accounts receivables | 97.48 Thousand | 48.74 Thousand | 48.74 Thousand | - | - | 219.58 Thousand |
| Accounts payables | -96.1 Thousand | - | - | - | - | -86.75 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -62.61 Thousand | -31.3 Thousand | -31.3 Thousand | - | - | -932.75 Thousand |
| Cash at beginning of period | 1.18 Million | 2.18 Million | - | 1.18 Million | -501.24 Thousand | 1.95 Million |
| Cash at end of period | 1.33 Million | 1.33 Million | -423.82 Thousand | 2.18 Million | 501.75 | 1.18 Million |
| Capital Expenditure | - | - | - | - | - | -19 Thousand |
| Effect of forex changes on cash | 54.52 Thousand | 25.73 Thousand | 25.73 Thousand | 1532.00 | 1532.00 | 75.84 Thousand |
| Net cash flow / Change in cash | 155.84 Thousand | -847.65 Thousand | -423.82 Thousand | 1 Million | 501.74 Thousand | -773.15 Thousand |
| Free Cash Flow | -2.16 Million | -1 Million | -504.43 Thousand | -1.15 Million | -577.14 Thousand | -7.05 Million |
ADVENZYMES
MGRD
SBM
DCNSF
VTMTF
8386